Form 4: Adagio Medical CFO Buys 15,000 Shares in Open Market

Adagio Medical Holdings, Inc.'s Chief Financial Officer, Deborah Kaster, reported an open market purchase of 15,000 shares of common stock.

Summary

• Deborah Kaster, Chief Financial Officer of Adagio Medical Holdings, Inc. (ADGM), acquired 15,000 shares of common stock.
• The transaction was an open market purchase, executed on December 16, 2025.
• The shares were purchased at a weighted average price of $1.1982 per share.
• The total value of the transaction was approximately $17,973.
• This purchase was made pursuant to a Rule 10b5-1 trading plan.
• Following this transaction, Deborah Kaster directly beneficially owns 15,000 shares of Adagio Medical Holdings, Inc. common stock.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to an insider purchase, indicating management confidence. However, the unusual future transaction date introduces a minor element of uncertainty or potential error.

Positives

• An insider, the Chief Financial Officer, purchased shares, which can signal confidence in the company's future prospects.
• The purchase was made under a Rule 10b5-1 plan, indicating a pre-planned investment strategy.

Negatives

• The reported transaction date of December 16, 2025, is in the future relative to the filing date of December 18, 2025, which is highly unusual for a Form 4 and may indicate a clerical error or an atypical reporting scenario.

Risks

• The discrepancy in the transaction date (future date reported) could lead to confusion or questions regarding the accuracy of the filing.
• While insider buying is generally positive, the relatively small transaction size (15,000 shares) may not be a strong indicator of significant future performance.

Future Outlook

The filing does not provide explicit forward-looking statements or guidance, but insider purchases can be interpreted as a positive signal regarding management's outlook on the company's future performance.

Industry Context

Insider buying, particularly by a Chief Financial Officer, can be viewed by the market as a sign of confidence in the company's valuation and future prospects within the medical device or healthcare technology sector.

Stakeholder Impact

• Shareholders may view the CFO's purchase as a positive signal, potentially increasing investor confidence in the company's stock.
• Employees might interpret the insider buying as a sign of stability and positive internal outlook.

Key Dates

Keywords

Adagio Medical Holdings, ADGM, Insider Trading, Form 4, Deborah Kaster, CFO, Stock Purchase, Rule 10b5-1, Beneficial Ownership